17 August 2017
Visiongain’s new report Global Computed Tomography (CT) Scan Market Forecast 2017-2027: Revenue Prospects by Product (High-Slice CT, Medium Slice CT and Low Slice CT), End-use (Hospitals, Diagnostic Centres) and Geography indicates that the CT Scan market will see over $5.3bn in revenue in 2017.
The lead analyst of the report said:
“The CT scan market is expected to grow at a healthy CAGR over the study period. Some of the major factors attributing to the growth of the market are increasing incidence and prevalence of various cardiovascular diseases, neurological disorders, various cancers, and orthopaedic diseases.
Advances in digital imaging technology, rising awareness in regards to screening and early diagnosis of cancer and chronic cardiovascular diseases, growing geriatric population, and increasing public awareness are further expected to fuel market growth. Changes in wealth and lifestyle globally, particularly in the BRICS emerging economies, will lead to a rise in the number of patients with a variety of cancers and the increase in the number of people undergoing CT scans for treatment and diagnosis.
All these factors coupled with the safety concerns with the use of CT scanners will see the market grow at a slow but steady pace over the forecast period. However, lack of adequate insurance coverage and demand for refurbished equipment in developing and underdeveloped regions are expected to restraint market growth during the forecast period.”
The 143-page report contains 85 tables, charts and graphs that add visual analysis in order to explain developing trends within the Computed Tomography market. Visiongain provides revenue forecasts for the period 2017-2027 for the leading CT submarkets, segmented by product type, with forecasts for High, medium and low-slice CT scanning devices. The market is also segmented by end-user, with forecasts for Hospitals, Diagnostic Centres and others.
The 143-page report offers market forecasts and analysis for 13 national markets. In addition, the report contains a dedicated leading companies’ chapter covering 7 companies leading the CT field in detail.
The Global Computed Tomography (CT) Scan Market Forecast 2017-2027: Revenue Prospects by Product (High-Slice CT, Medium Slice CT and Low Slice CT), End-use (Hospitals, Diagnostic Centres) and Geography report will be of value to anyone who wants to better understand the Computed Tomography market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the CT Scanning industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.
25 November 2022
Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.
25 November 2022
The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.
23 November 2022
The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.